WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after a well-known pharmaceutical company in Europe to boost ...

SK Square Co., the investment arm of South Korea’s No. 2 conglomerate SK Group, announced shareholder-friendly measures on Thursday, in response to activist fund Palliser Capital’s push to boost ...